Analyst Ratings for Arrowhead Pharma (ARWR)
ARWR Rating Summary
ARWR Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$87.00 (+17.1%)
* Over Last 12-Mos
Rating Score: 7.4 / 10
Percentile Rank: 77%
Avg. $ Target:
$87.00 (+17.1%)
* Over Last 12-Mos
Rating Score: 7.4 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Stifel | James Condulis | New Coverage | Buy (N/A) |
98.00 (N/A) |
76.40 (74.30) |
-2.75% | Details |
| 5/1/2026 | JPMorgan | Brian Cheng | New Coverage | Overweight (N/A) |
88.00 (N/A) |
70.53 (74.30) |
5.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
